Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Anne Engesser et al.|Clinical Cancer Research|2014Cited by 99
Age‐dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaSimona Coco, Gian Paolo Tonini|International Journal of Cancer|2012Cited by 57
Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumoursPina Fusco, Gian Paolo Tonini|BMC Cancer|2019Cited by 37
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0